Scalable Technology for the Extraction of Pharmaceutics (STEP): the transition from academic knowhow to industrial reality.

This paper addresses the technological readiness of counter-current chromatography (CCC) instruments to become platform technology for the pharmaceutical industry. It charts the development of the prototype technology since its inception in 1966, through conceptual improvements in the 1980s that led to higher speed separations in hours as opposed to days. It then describes the engineering improvements that have led to the development of high performance counter-current chromatography with the potential for scale-up to process scale for manufacturing products in industry with separation times in minutes rather than hours. A new UK Technology Strategy Board high value manufacturing £1.5 m research programme to take CCC through to technology readiness level 8 (i.e. as platform technology for continuous 24 × 7 operation by industry) is introduced. Four case studies are given as examples of successes from its expanding applications portfolio, which is mainly confidential. Finally, the hurdles for the uptake of new technology by industry are highlighted and the following potential solutions given: rapid method development, automation, continuous processing and instrument reliability and robustness. The future challenge for the CCC community will be to address these development needs urgently if CCC is to become the platform technology it deserves to be.

A novel approach to modelling counter-current chromatography.

Literature lists a number of counter-current chromatography (CCC) models that can predict the retention time and to a certain extent the peak width of a solute eluting from a CCC column. The approach described in this paper distinguishes itself from previous reports by relating all model parameters directly to column dimensions and experimental settings. Most importantly, this model can predict a chromatogram from scratch without resorting to traditional calibration using empirical values. The model validation with experimental results obtained across a range of CCC instruments demonstrated that the solute retention time, peak width, and peak resolution could be predicted within reasonable accuracy. Additionally, the effect of several process parameters, such as mobile phase flow rate, rotational speed of the column or ß-value, showed that the model is robust and applicable to a wide range of CCC instruments. Overall, this model proved to be a useful tool for parameter estimation and, most significantly, separation optimisation.

Performance comparison using the GUESS mixture to evaluate counter-current chromatography instruments.

Comparing the performance of different counter-current chromatography (CCC) J-type centrifuges has and will always be difficult. This is due to the number of variables such as speed of rotation, swung radius, beta-value, column bore, column length that can be chosen during the design of an instrument. This situation is further complicated by the implication that some of these variables are intrinsically linked, such that if one is changed another or others can also change. The chromatographer has no influence on these hardware parameters once the instrument designer has chosen them. However, the chromatographer wants a CCC column that retains the most liquid stationary phase in order to achieve the best separation of the components in a mixture. What matters most is column performance in terms of: sample loading per injection, speed of separation, purity of target and yield of target. The instrument that has the best performance in all these areas is called a "high-performance" CCC system. This paper demonstrates to the modern chromatographer that a "high-performance" CCC instrument has shorter, lower volume columns that are rotated faster to provide quicker separations, even with the same sample loading.

A short synthesis of D-glycero-D-manno-heptose 7-phosphate.

D-glycero-D-manno-Heptopyranose 7-phosphate-an intermediate in the biosynthesis of nucleotide-activated heptoses-has been prepared in good overall yield from benzyl 5,6-dideoxy-2,3-O-isopropylidene-alpha-D-lyxo-(Z)-hept-5-enofuranoside by a short-step synthesis. Phosphitylation using the phosphoramidite procedure followed by in situ oxidation afforded the corresponding 7-O-phosphotriester derivative in high yield. Subsequent osmylation proceeded in good diastereoselectivity (4:1) to furnish the D-glycero-D-manno-configured derivative, which was separated from the L-glycero-L-gulo-isomer by chromatography. Hydrogenolysis led to simultaneous removal of the benzyl and isopropylidene groups and afforded the target compound in high yield, which serves as a substrate of bacterial heptose 7-phosphate kinases.